Company news
Cogent Biosciences, Inc. news in 2021
Cogent Biosciences, Inc.'s news releases, calls and decks from 2021, newest first.
Cogent Biosciences to Present at Piper Sandler 33rd Annual Virtual Healthcare Conference
November 21, 2021
Cogent Biosciences Provides Corporate Updates and Reports Third Quarter 2021 Financial Results
November 9, 2021
Cogent Biosciences to Present Virtually at Jefferies London Healthcare Conference 2021
November 1, 2021
Cogent Biosciences Presents New Preclinical Data Demonstrating Bezuclastinib as a Differentiated KIT Inhibitor with Minimal Brain Penetration
October 6, 2021
Cogent Biosciences to Present Preclinical Data on Bezuclastinib at AACR-NCI-EORTC Conference
September 30, 2021
Cogent Biosciences Provides Corporate Updates and Reports Second Quarter 2021 Financial Results
August 15, 2021
Cogent Biosciences to Present at Wedbush PacGrow Virtual Healthcare Conference 2021
July 26, 2021
Cogent Biosciences to Present at Ladenburg Thalmann Virtual Healthcare Conference 2021
June 28, 2021
Cogent Biosciences to Present at Jefferies Virtual Healthcare Conference 2021
May 25, 2021
Cogent Biosciences Provides Corporate Updates and Reports First Quarter 2021 Financial Results
May 11, 2021
Cogent Biosciences Appoints Evan Kearns as Chief Legal Officer
May 2, 2021
Cogent Biosciences Announces Creation of Cogent Research Team
April 5, 2021
Cogent Biosciences Reports Fourth Quarter 2020 and Full Year 2020 Financial Results
March 15, 2021
Cogent Biosciences Appoints Accomplished Finance Executive Todd E. Shegog to its Board of Directors
February 21, 2021
Cogent Biosciences to Present at Virtual 10th Annual SVB Leerlink Global Healthcare Conference 2021
February 17, 2021
Cogent Biosciences to Present at LifeSci Partners Virtual Precision Oncology Day 2021
February 10, 2021